William B. Rowland (Bill)

Partner

Atlanta + 1.404.581.8961

Bill Rowland represents significant companies in M&A and other transactional matters, crafting pragmatic solutions to clients' complex business and legal needs. Clients have turned to Bill for more than 35 years to achieve their transactional goals. His practice focuses on domestic and cross-border mergers and acquisitions, divestitures, joint ventures, corporate governance, and takeovers. He is the coordinator of the Atlanta Office transactional practices.

Bill represents both public and private companies across an array of industries including chemicals, energy, manufacturing, and technology. Representative transactions include Guardian Pharmacy's initial public offering; Eastman Chemical's divestiture of its Texas City operations ($490 million), adhesives resins business ($1 billion), and rubber additives business ($800 million); Eastman Chemical's acquisitions of Solutia ($4.8 billion) and Taminco ($2.8 billion); Southern Company's acquisition of AGL Resources ($12 billion) and divestiture to NextEra Energy ($6.5 billion); and J.M. Huber's divestiture to Evonik ($630 million). Bill has led substantial matters for a number of other clients including Solvay, Syensqo, Cumulus Media, and Koch Industries.

Bill is the former chair of the Business Law Section of the State Bar of Georgia. He has served on the board of directors of the Alliance Theatre, the Georgia Council for International Visitors, and the Swedish-American Chamber of Commerce. He is a member of the Leadership Atlanta Class of 2009. Bill's work has been recognized in various legal surveys including The Best Lawyers in America and Chambers USA.